Table 1.
Canonical Pathways [43] | P value | Canonical Pathways[44] | P value |
---|---|---|---|
NF-κB signaling | 0.01 | ATM signaling | 0.00006 |
Toll like receptor signaling | 0.02 | LPS-stimulated MAPK signaling | 0.0007 |
CD28 signaling in T helper cells | 0.04 | CC receptor 3 signaling in eosinophils | 0.0001 |
Leukocyte extravasation signaling | 0.04 | Chemokine signaling | 0.001 |
CXCR4 signaling | 0.05 | T-cell receptor signaling | 0.01 |
Chemokine signaling | 0.06 | Toll-like receptor signaling | 0.02 |
B-cell receptor signaling | 0.06 | B-cell receptor signaling | 0.02 |
ATM signaling | 0.08 | IL-12 signaling and production in macrophages | 0.03 |
IL-4 signaling | 0.09 | IL-3 signaling | 0.03 |
IL-12 signaling and production in macrophages | 0.09 | IL-1 signaling | 0.04 |
IL-15 signaling | 0.1 | CXCR4 signaling | 0.04 |
Role of NFAT in the regulation of the immune response | 0.1 | MIF regulation of innate immunity | 0.05 |
IL-8 signaling | 0.05 | ||
Acute phase response signaling | 0.06 | ||
NF-κB signaling | 0.06 | ||
IL-17 signaling | 0.07 | ||
PI3K signaling in B lymphocytes | 0.1 | ||
B-cell activating factor signaling | 0.1 | ||
Role of NFAT in the regulation of the immune response | 0.1 |
NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells, ATM, ataxia telangiectasia-mutated; CD, cluster of differentiation; CXCR4, chemokine receptor type 4; IL, interleukin; NFAT, nuclear factor of activated T-cells; MIF, migration inhibitory factor; NK, natural killer; Fcγ, Fc gamma; PI3K, phosphatidylinositide 3-kinases; FcγRIIB, Fcγ receptor IIB; Wnt, Int and Wg gene; MAPK, mitogen-activated protein kinase; BAFF, B-cell activating factor;
The functional analysis presented in this table was generated through the use of IPA (Ingenuity Systems (www.ingenuity.com). Fisher’s exact test was used to calculate a P-value determining the probability that the association between the mutated genes and the canonical pathway could be explained by chance. Pro-inflammatory pathways in which mutated genes were detected in the study of Quesada et al. [43] are depicted in columns 1 and 2, and in the study of Wang et al. [44], in columns 3 and 4. Both studies detected mutations in genes crucial for an inflammatory response, including cytokine signaling pathways (eg: IL-6), innate immunity activation pathways (eg: TLR signaling), chemokine signaling (eg: CXCR4) and pro-inflammatory transcription factors (eg: NF-κB signaling).